簡易檢索 / 詳目顯示

研究生: 許煜承
Hsu, Yu-Cheng
論文名稱: 透過急性經皮耳迷走神經刺激對皮質-邊緣系統局部場電位的電生理調節:與壓力感受反射自動調節的機制區別
Electrophysiological Modulations of Cortico-Limbic Local Field Potentials via Acute Transcutaneous Auricular Vagus Nerve Stimulation: A Mechanistic Differentiation from Baroreflex Autoregulation
指導教授: 林宙晴
Lin, Chou-Ching K.
學位類別: 碩士
Master
系所名稱: 工學院 - 生物醫學工程學系
Department of BioMedical Engineering
論文出版年: 2026
畢業學年度: 114
語文別: 英文
論文頁數: 90
中文關鍵詞: 經皮耳迷走神經刺激 、局部場電位 、血反射 、孤束核 、後島葉皮質 、中央杏仁核 、gamma振盪
外文關鍵詞: Transcutaneous Auricular Vagus Nerve Stimulation (taVNS), Local Field Potentials (LFP), baroreflex, Nucleus Tractus Solitarius (NTS), Posterior Insular Cortex (PIC), Central Amygdala (CeM), gamma Oscillations
相關次數: 點閱:73  下載:0 
分享至:
查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統 勘誤回報
  • 【背景】
      經皮耳迷走神經刺激(transcutaneous auricular vagus nerve stimulation, taVNS)已被視為治療抗藥性癲癇與情緒障礙的一種具潛力的非侵入式神經調控方法。儘管其臨床療效已有相當研究支持,但 taVNS 對中央自主神經網路(central autonomic network, CAN)內即時頻帶特異性神經動態之影響,尤其是在後島葉皮質(posterior insular cortex, PIC)與杏仁核中央內側核(central medial amygdala, CeM)中的調控機制,仍未完全釐清。此外,迷走神經研究中的重要挑戰之一,在於區分所觀察到的中樞電生理變化是經由孤束核上行迷走神經傳入活化的直接結果,或僅為周邊壓力反射與血流動力學所驅動的次級效應。
    【方法】
      本研究以麻醉大鼠為動物模型,利用三通道(其一位於CeM,另外兩通道為雙螺旋通道位於PIC)局部場電位(local field potential, LFP)記錄,分析急性 taVNS 刺激前、後不同時間區段的神經活動變化。為進一步區分直接神經調控效應與被動自主神經回饋,本研究另建立藥理性壓力反射(baroreflex)對照組,透過去氧腎上腺素與硝普鈉誘發全身性血壓波動。壓力反射效應分別以兩種分析框架評估:注射前後 30 秒之急性窗口分析(Method A),以及縱向趨勢分析(Method B)。
    【結果】
      結果顯示,taVNS 與 baroreflex 組之間呈現明顯不同的神經電生理特徵。於 taVNS 停止後,功率譜密度(PSD)整體呈上升趨勢,在中央杏仁核(CeM)與後島葉皮質(PIC)區域皆觀察到 alpha 頻段(8-12 Hz)的功率調升趨勢。此外,taVNS 成功突破深度麻醉下的代謝抑制狀態,於 PIC 通道誘發出高度一致的響應性 gamma 頻段(55-70 Hz)活化。相較之下,baroreflex 對照組在周邊血壓劇烈波動下,並未引發高頻 gamma 的同步活化,僅於低血壓恢復階段呈現局部性的 delta 頻段衰減,且完全未觀察到跨區域 alpha 或皮質 gamma 頻段的顯著響應。
    【討論】
      相較之下,baroreflex 對照組在急性升壓衝擊下雖然引發了短暫的 theta 抑制(*p=0.031),並於藥效消退的恢復階段(Rest vs. Vaso)呈現次級的 alpha 功率衰減(*p=0.047),但完全未出現類似於 taVNS 的高頻 gamma 活化或跨區域 alpha 功率提升。顯示 taVNS 所誘發的中樞電生理變化並非單純來自周邊血流動力學效應,而較可能與上行迷走神經傳入活化直接相關。機制上,PIC區域之gamma增強可能反映皮質去同步化(desynchronization)狀態,有助於抑制癲癇相關病理同步活動;而CeM中的alpha增強則可能涉及杏仁核中央外側核(central lateral amygdala, CeL)至中央內側核CeM去抑制迴路之神經調控,並與抗焦慮效應相關。整體而言,本研究支持taVNS具有直接調控皮質-邊緣系統網路活動之能力,並提供其神經生物學機制的重要實驗證據。

    [Background]
    Transcutaneous auricular vagus nerve stimulation (taVNS) has emerged as a promising non-invasive neuromodulatory approach for treatment-resistant epilepsy and affective disorders. Although its clinical efficacy is well supported, the immediate impact of acute taVNS on real-time, band-specific neural dynamics within the central autonomic network (CAN)—particularly its regulatory mechanisms in the posterior insular cortex (PIC) and the central amygdala (CeM)—remains incompletely understood. Furthermore, a major challenge in vagal nerve research is distinguishing whether these observed central electrophysiological changes are direct consequences of ascending vagal afferent activation via the nucleus tractus solitarius (NTS), or merely secondary effects driven by peripheral baroreflex and hemodynamic regulation.
    [Methods]
    To address these gaps, this study utilized multi-channel local field potential (LFP) recordings in anesthetized rat models to track the real-time chronological adjustments across pre-, peri-, and post-stimulation temporal windows under an acute taVNS protocol. Crucially, to isolate direct neuromodulatory effects from passive autonomic feedback, a standalone pharmacological baroreflex control cohort was established. Systemic blood pressure fluctuations were dynamically induced using Phenylephrine and Sodium Nitropruss, and evaluated across two distinct scales: an acute 30-second pre-to-post injection window (Approach A) and a longitudinal trend analysis (Approach B).
    [Results]
    The empirical data unveiled a distinct neurobiological divergence between the two cohorts. Following the cessation of acute taVNS, a generalized upward shift in power spectral density was captured across individual subject profiles, presenting as consistent low-frequency alpha (8-12 Hz) power elevations within both the subcortical CeM and cortical PIC nodes. Most notably, active taVNS successfully broke through the metabolic depression of deep anesthesia, triggering a robust and highly reproducible enhancement localized within the high-frequency responsive gamma band (55-70 Hz) in the posterior insular channels. Conversely, the standalone baroreflex control group exhibited localized, minor shifts restricted primarily to the delta band during severe hypotensive transitions, while maintaining stationary gamma and alpha dynamics during hemodynamic surges.
    [Discussion]
    In contrast, the baroreflex control group exhibited acute theta suppression (*p=0.031) alongside a secondary post-pressor alpha decay during the 10-minute recovery phase (*p=0.047, Rest relative to Vaso), while completely failing to engage high-frequency gamma networks or mimic the spectral elevations observed post-taVNS. Instead, they are validated as direct central effects mediated specifically by ascending transcutaneous vagal recruitment. Mechanistically, the localized post-stimulation insular gamma enhancement reflects a state of cortical desynchronization capable of destabilizing the pathological synchrony underlying ictal progression, providing an empirical baseline for anticonvulsant actions. Simultaneously, the alpha modulation within the CeM implies an electrophysiological gating mechanism within the central lateral amygdala (CeL)–CeM inhibitory loop, offering a neural substrate for clinical anxiolytic regulation. Together, these findings solidify the neurobiological validity of taVNS and provide crucial insights into real-time cortico-limbic network interventions.

    摘要 i Abstract ii 誌謝 iv Declaration on the Use of Artificial Intelligence and AI-Assisted Technologies vi List of Contents vii List of Tables x List of Figures xi CHAPTER 1 INTRODUCTION 1 1.1 The VNS-NTS-Limbic Circuit: The Neuroanatomical Foundation of Vagus Nerve Stimulation 1 1.2 Modalities of VNS 2 1.2.1 Overview of Invasive and Non-Invasive Vagus Nerve Stimulation 2 1.2.2 Clinical Advantages and Mechanisms of taVNS 5 1.3 Mechanisms of Central Network Regulation via Vagal Modulation of the Posterior Insula and Central Amygdala 6 1.4 TaVNS Effects on Typical Frequency Bands 8 1.5 Experimental Exploration of NTS-Mediated Baroreflex Modulations: Impact on Autonomic Stability 10 1.6 Safety Considerations and Stimulation Parameter Configurations for taVNS 13 1.7 Current Research Lacunae and the Critical Imperative of Local Field Potential (LFP) Recording 14 1.8 Research Hypotheses and Thesis Objectives 15 CHAPTER 2 MATERIALS AND METHODS 16 2.1 Experimental Animals 16 2.1.1 Animal Preparation and Ethic Statement 16 2.1.2 Grouping: taVNS and baroreflex Subjects 16 2.2 Surgical Procedures and Data Acquisition 18 2.2.1 Selection and Specification of Recording Electrodes 18 2.2.2 Signal Acquisition System and Instrumentation 18 2.3 Experimental Protocols 21 2.3.1 Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) 21 2.3.2 Baroreflex: Pharmacological Induction of Blood Pressure Fluctuations 25 2.4 Histological Verification 28 2.5 Signal Processing and Feature Extraction 29 2.5.1 Group-Specific Digital Filtering and Power Line Hum Noise Removal 29 2.5.2 Artifact Rejection via Median Absolute Deviation (MAD) and Voltage Threshold 30 2.5.3 Timeline Segmentation and Analytics for the taVNS Group 32 2.5.4 Data array Segmentation and Analytics for the baroreflex Group 32 2.6 Statistical Analysis 34 2.6.1 Baroreflex Group Analytics 34 2.6.2 TaVNS Group Analytics 34 CHAPTER 3 RESULTS 36 3.1 Acute Pre- vs. Post-Injection Comparison Intra-phase of both Vaso and Depre phases (Approach A) 36 3.2 baroreflex Group Results: Time-Anchored Longitudinal Trend Analysis of NTS LFP (Approach B) 39 3.2.1 Continuous Rolling Variation Rate of NTS LFP Bands Across Sustained Blocks 39 3.2.2 Phase-Rolling Alterations and Multi-Phase Trends 39 3.3 Results of taVNS Group 47 3.3.1 Representative LFP Responses to taVNS 47 3.2.2 Methodological Challenges: Environmental and Physiological Artifacts 51 3.3.3 Statistical Profiling of Normalized Power Spectral Density (PSD) 56 3.4 Histological Verification of Surgical Implantation and Targeting Accuracy 61 CHAPTER 4 DISCUSSION 64 4.1 Methodological Contrast of Central Spectral Profiles 64 4.2 Functional Implications of Channel and Band Specificity 66 4.3 Neuroanatomical Circuits and the Confounding Effects of Deep Anesthesia on Theta Oscillations 67 4.4 Translational Implications for Clinical Neuromodulation 69 4.4.1 Cortical Gamma Oscillations in the Posterior Insula and Anticonvulsant Mechanisms 69 4.4.2 Amygdaloid Alpha Shifts and Anxiolytic Regulation via the CeL-CeM Inhibitory Loop 69 CHAPTER 5 CONCLUSION AND FUTURE WORK 71 5.1 Conclusion 71 5.2 Future Work 72 Reference 73

    1. Austelle, C.W., et al., A comprehensive review of vagus nerve stimulation for depression. Neuromodulation: Technology at the Neural Interface, 2022. 25(3): p. 309–315.
    2. Bottomley, J.M., et al., Vagus nerve stimulation (VNS) therapy in patients with treatment resistant depression: a systematic review and meta-analysis. Comprehensive psychiatry, 2020. 98: p. 152156.
    3. Ali, M.S.S., et al., Genetic labeling of the nucleus of tractus solitarius neurons associated with electrical stimulation of the cervical or auricular vagus nerve in mice. Brain stimulation, 2024. 17(5): p. 987–1000.
    4. Zhang, S.-Q., et al., Repeated vagus nerve stimulation produces anxiolytic effects via upregulation of AMPAR function in centrolateral amygdala of male rats. Neurobiology of Stress, 2022. 18: p. 100453.
    5. Lanska, D.J., JL Corning and vagal nerve stimulation for seizures in the 1880s. Neurology, 2002. 58(3): p. 452–459.
    6. Howland, R.H., Vagus nerve stimulation. Current behavioral neuroscience reports, 2014. 1(2): p. 64–73.
    7. Hammer, N., et al., Human Vagus Nerve Branching in the Cervical Region. PLOS ONE, 2015. 10(2): p. e0118006.
    8. Ellrich, J., Transcutaneous Auricular Vagus Nerve Stimulation. Journal of Clinical Neurophysiology, 2019. 36(6): p. 437–442.
    9. Ay, I., V. Napadow, and H. Ay, Electrical stimulation of the vagus nerve dermatome in the external ear is protective in rat cerebral ischemia. Brain stimulation, 2015. 8(1): p. 7–12.
    10. Badran, B.W., et al., Neurophysiologic Effects of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) via Electrical Stimulation of the Tragus: A Concurrent taVNS/fMRI Study and Review. Focus, 2022. 20(1): p. 80–89.
    11. Bucksot, J.E., et al., Parametric characterization of the rat Hering-Breuer reflex evoked with implanted and non-invasive vagus nerve stimulation. Experimental neurology, 2020. 327: p. 113220.
    12. Gail, M.W., et al., Transcutaneous auricular vagus nerve stimulation (taVNS) decreases heart rate acutely in neonatal rats. Brain Stimulation: Basic, Translational, and Clinical Research in Neuromodulation, 2023. 16(5): p. 1240–1242.
    13. Machetanz, K., et al., Brain–Heart Interaction During Transcutaneous Auricular Vagus Nerve Stimulation. Frontiers in Neuroscience, 2021. Volume 15 - 2021.
    14. Mahadi, K., et al., Cardiovascular autonomic effects of transcutaneous auricular nerve stimulation via the tragus in the rat involve spinal cervical sensory afferent pathways. Brain stimulation, 2019. 12(5): p. 1151–1158.
    15. Sclocco, R., et al., The influence of respiration on brainstem and cardiovagal response to auricular vagus nerve stimulation: A multimodal ultrahigh-field (7T) fMRI study. Brain stimulation, 2019. 12(4): p. 911–921.
    16. Usami, K., et al. Modulation of cortical synchrony by vagus nerve stimulation in adult rats. in 2013 35th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC). 2013. IEEE.
    17. Ben-Menachem, E., Vagus nerve stimulation, side effects, and long-term safety. J Clin Neurophysiol, 2001. 18(5): p. 415–8.
    18. Giordano, F., et al., Vagus nerve stimulation: Surgical technique of implantation and revision and related morbidity. Epilepsia, 2017. 58 Suppl 1: p. 85–90.
    19. Nawaz, H., I. Shah, and S. Ali, The amygdala connectivity with depression and suicide ideation with suicide behavior: A meta-analysis of structural MRI, resting-state fMRI and task fMRI. Progress in neuro-psychopharmacology and biological psychiatry, 2023. 124: p. 110736.
    20. Frangos, E., J. Ellrich, and B.R. Komisaruk, Non-invasive access to the vagus nerve central projections via electrical stimulation of the external ear: fMRI evidence in humans. Brain stimulation, 2015. 8(3): p. 624–636.
    21. Ricci, L., et al., Transcutaneous vagus nerve stimulation modulates EEG microstates and delta activity in healthy subjects. Brain sciences, 2020. 10(10): p. 668.
    22. Rizzo, P., et al., Modifications of sleep EEG induced by chronic vagus nerve stimulation in patients affected by refractory epilepsy. Clinical Neurophysiology, 2004. 115(3): p. 658–664.
    23. Golanov, E.V. and D.J. Reis, Neurons of nucleus of the solitary tract synchronize the EEG and elevate cerebral blood flow via a novel medullary area. Brain Research, 2001. 892(1): p. 1–12.
    24. Lewine, J.D., et al., Exploration of the impact of brief noninvasive vagal nerve stimulation on EEG and event-related potentials. Neuromodulation: Technology at the Neural Interface, 2019. 22(5): p. 564–572.
    25. Keute, M., et al., Effects of transcutaneous vagus nerve stimulation (tVNS) on beta and gamma brain oscillations. Cortex, 2021. 140: p. 222–231.
    26. Broncel, A., et al., Medial septal cholinergic mediation of hippocampal theta rhythm induced by vagal nerve stimulation. PLoS One, 2018. 13(11): p. e0206532.
    27. Broncel, A., et al., GABAergic mediation of hippocampal theta rhythm induced by stimulation of the vagal nerve. Brain Research Bulletin, 2019. 147: p. 110–123.
    28. Jia, F., et al., Isoflurane Is a Potent Modulator of Extrasynaptic GABAA Receptors in the Thalamus. The Journal of Pharmacology and Experimental Therapeutics, 2008. 324(3): p. 1127–1135.
    29. Jung, J. and T. Kim, General anesthesia and sleep: like and unlike. Anesth Pain Med (Seoul), 2022. 17(4): p. 343–351.
    30. Topf, N., et al., Effects of isoflurane on gamma-aminobutyric acid type A receptors activated by full and partial agonists. Anesthesiology, 2003. 98(2): p. 306–11.
    31. Légat, L., I. Smolders, and A.G. Dupont, Angiotensin-II-mediated AT1 receptor stimulation increases glutamate release within the rostral ventrolateral medulla of normotensive rats. Hypertension Research, 2020. 43(8): p. 848–850.
    32. Sved, A.F., et al., Excitatory inputs to the RVLM in the context of the baroreceptor reflex. Annals of the New York Academy of Sciences, 2001. 940(1): p. 247–258.
    33. Benarroch, E.E., Sympathetic System; Overview, in Encyclopedia of the Neurological Sciences (Second Edition), M.J. Aminoff and R.B. Daroff, Editors. 2014, Academic Press: Oxford. p. 372–375.
    34. Mischel, N.A., et al., (In) activity-related neuroplasticity in brainstem control of sympathetic outflow: unraveling underlying molecular, cellular, and anatomical mechanisms. American Journal of Physiology-Heart and Circulatory Physiology, 2015. 309(2): p. H235–H243.
    35. Yosten, G.L.C. and W.K. Samson, Chapter 13 - Cardiovascular Neuroendocrinology, in Handbook of Neuroendocrinology, G. Fink, D.W. Pfaff, and J.E. Levine, Editors. 2012, Academic Press: San Diego. p. 307–327.
    36. Cogan, S.F., et al., Tissue damage thresholds during therapeutic electrical stimulation. Journal of neural engineering, 2016. 13(2): p. 021001.
    37. Lilly, J.C., et al., Brief, Noninjurious Electric Waveform for Stimulation of the Brain. Science, 1955. 121(3144): p. 468–469.
    38. Shannon, R.V., A model of safe levels for electrical stimulation. IEEE Transactions on biomedical engineering, 2002. 39(4): p. 424–426.
    39. Wang, Z., et al., Effects of stable vagus nerve stimulation efficacy on autistic behaviors in ten pediatric patients with drug resistant epilepsy: an observational study. Frontiers in pediatrics, 2022. 10: p. 846301.
    40. Günter, C., J. Delbeke, and M. Ortiz-Catalan, Safety of long-term electrical peripheral nerve stimulation: review of the state of the art. Journal of neuroengineering and rehabilitation, 2019. 16(1): p. 13.
    41. Mortimer, J.T., D. Kaufman, and U. Roessmann, Intramuscular electrical stimulation: tissue damage. Annals of biomedical engineering, 1980. 8(3): p. 235–244.
    42. Yeh, S., Comparative anorectic effects of metaraminol and phenylephrine in rats. Physiology & behavior, 1999. 68(1-2): p. 227–234.
    43. Soares, A.C., et al., Activation of ATP-sensitive K+ channels: mechanism of peripheral antinociceptive action of the nitric oxide donor, sodium nitroprusside. European journal of pharmacology, 2000. 400(1): p. 67–71.
    44. Kheirati Roonizi, A., Digital IIR filters: Effective in edge preservation? Signal Processing, 2024. 221: p. 109492.
    45. Aksenov, D.P., et al., The effect of sevoflurane and isoflurane anesthesia on single unit and local field potentials. Experimental brain research, 2019. 237(6): p. 1521–1529.
    46. Jiang, J., et al., Signatures of thalamocortical alpha oscillations and synchronization with increased anesthetic depths under isoflurane. Frontiers in Pharmacology, 2022. 13: p. 887981.
    47. Wang, R., et al., Electrophysiological activity pattern of mouse hippocampal CA1 and dentate gyrus under isoflurane anesthesia. Frontiers in Cellular Neuroscience, 2024. Volume 18 - 2024.
    48. Leung, L.S., et al., Medial septal lesion enhances general anesthesia response. Experimental Neurology, 2013. 247: p. 419–428.
    49. Tai, S.K., J. Ma, and L.S. Leung, Medial septal cholinergic neurons modulate isoflurane anesthesia. 2014.
    50. Cardin, J.A., et al., Driving fast-spiking cells induces gamma rhythm and controls sensory responses. Nature, 2009. 459(7247): p. 663–667.
    51. Kano, R., et al., Vagus Nerve Stimulation-Induced Synchrony Modulation of Local Field Potential in the Rat Cerebral Cortex. Electronics and Communications in Japan, 2015. 98(3): p. 47–56.
    52. McDonald, A.J. and T.R. Jackson, Amygdaloid connections with posterior insular and temporal cortical areas in the rat. Journal of Comparative Neurology, 1987. 262(1): p. 59–77.
    53. McIntyre, C.K., Is There a Role for Vagus Nerve Stimulation in the Treatment of Posttraumatic Stress Disorder? Bioelectronics in Medicine, 2018. 1(2): p. 95–99.
    54. Noble, L.J., et al., Effects of vagus nerve stimulation on extinction of conditioned fear and post-traumatic stress disorder symptoms in rats. Translational Psychiatry, 2017. 7(8): p. e1217–e1217.
    55. Powers, M.B., et al., Vagus nerve stimulation therapy for treatment-resistant PTSD. Brain Stimulation, 2025. 18(3): p. 665–675.
    56. Mathew, E., et al., Vagus nerve stimulation produces immediate dose-dependent anxiolytic effect in rats. Journal of Affective Disorders, 2020. 265: p. 552–557.

    下載圖示
    校外:立即公開
    QR CODE